Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: Results from a randomized double blind placebo controlled pilot study

The Brief Psychiatric Rating Scale.

Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090 · see citing works

Untitled work

(1976) · Medical Entomology and Zoology · Cited by 8,899 · see citing works

Oxytocin increases trust in humans

Kosfeld, M., Heinrichs, M., Zak, P. J., Fischbacher, U., & Fehr, E. (2005) · Nature · doi:10.1038/nature03701 · Cited by 3,690 · see citing works

Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress

Heinrichs, M., Baumgartner, T., Kirschbaum, C., & Ehlert, U. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00465-7 · Cited by 2,091 · see citing works

Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine

Meyer-Lindenberg, A., Domes, G., Kirsch, P., & Heinrichs, M. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3044 · Cited by 1,688 · see citing works

The neurobiology of pair bonding.

Young, L. J., & Wang, Z. (2004) · Nature Neuroscience · doi:10.1038/nn1327 · Cited by 1,523 · cited 3× · see citing works

Deficit and nondeficit forms of schizophrenia: the concept

Carpenter, W. T., Heinrichs, D. W., & Wagman, A. M. I. (1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.5.578 · Cited by 1,329 · see citing works

The NIMH-MATRICS Consensus Statement on Negative Symptoms

Kirkpatrick, B., Fenton, W. S., Carpenter, W. T., & Marder, S. R. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj053 · Cited by 1,311 · see citing works

University of pennsylvania smell identification test: A rapid quantitative olfactory function test for the clinic

Doty, R. L., Shaman, P., Kimmelman, C. P., & Dann, M. S. (1984) · The Laryngoscope · doi:10.1288/00005537-198402000-00004 · Cited by 875 · see citing works

The Structure of Negative Symptoms Within Schizophrenia: Implications for Assessment

Blanchard, J. J., & Cohen, A. S. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj013 · Cited by 649 · see citing works

The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments

Buchanan, R. W., Javitt, D. C., Marder, S. R., Schooler, N. R., Gold, J. M., McMahon, R. P., Heresco-Levy, U., & Carpenter, W. T. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06081358 · Cited by 419 · see citing works

A critical review of the influence of oxytocin nasal spray on social cognition in humans: Evidence and future directions

Graustella, A. J., & MacLeod, C. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2012.01.002 · Cited by 379 · see citing works

Localization of high-affinity binding sites for oxytocin and vasopressin in the human brain. An autoradiographic study

Loup, F., Tribollet, E., Dubois-Dauphin, M., & Dreifuss, J. J. (1991) · Brain Research · doi:10.1016/0006-8993(91)90345-v · Cited by 378 · see citing works

Olfactory Dysfunction in Schizophrenia A Qualitative and Quantitative Review

Moberg, P. J. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00019-6 · Cited by 317 · see citing works

Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients

Feifel, D., Macdonald, K., Nguyen, A., Cobb, P., Warlan, H., Galangue, B., Minassian, A., Becker, O., Cooper, J., Perry, W., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.039 · Cited by 308 · see citing works

Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia

Pedersen, C. A., Gibson, C. M., Rau, S. W., Salimi, K., Smedley, K. L., Casey, R. L., Leserman, J., Jarskog, L. F., & Penn, D. L. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.07.027 · Cited by 305 · see citing works

Oxytocin, vasopressin and pair bonding: implications for autism

Hammock, E. A. D., & Young, L. J. (2006) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2006.1939 · Cited by 289 · see citing works

Neural Mechanisms of Anhedonia in Schizophrenia

Crespo‐Facorro, B., Paradiso, S., Andreasen, N. C., OʼLeary, D. S., Watkins, G. L., Ponto, L. L. B., & Hichwa, R. D. (2001) · JAMA · doi:10.1001/jama.286.4.427 · Cited by 232 · see citing works

Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophrenia.

Brewer, W., Wood, S., McGorry, P., Francey, S., Phillips, L., Yung, A., Anderson, V., Copolov, D., Singh, B. S., Velakoulis, D., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.10.1790 · Cited by 195 · see citing works

Emotion recognition and oxytocin in patients with schizophrenia

Averbeck, B. B., Bobin, T., Evans, S., & Shergill, S. S. (2011) · Psychological Medicine · doi:10.1017/s0033291711001413 · Cited by 144 · see citing works

Neuropsychological, olfactory, and hygiene deficits in men with negative symptom schizophrenia

Brewer, W. J., Edwards, J., Anderson, V. A., Robinson, T., & Pantelis, C. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00594-3 · Cited by 140 · see citing works

Stability of Olfactory Identification Deficits in Neuroleptic-Naive Patients With First-Episode Psychosis

Brewer, W. J., Pantelis, C., Anderson, V. A., Velakoulis, D., SINGH, B. S., Copolov, D., & McGorry, P. D. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.1.107 · Cited by 140 · see citing works

Assessment of capacity to give consent to research participation: state-of-the-art and beyond.

DeRenzo, E. G., Conley, R. R., & Love, R. (1998) · PubMed · Cited by 123 · see citing works

Olfactory hallucinations and olfactory identification ability in patients with schizophrenia and other psychiatric disorders

Kopala, L. C., Good, K. P., & Honer, W. G. (1994) · Schizophrenia Research · doi:10.1016/0920-9964(94)90030-2 · Cited by 122 · see citing works

Olfactory identification deficits in schizophrenia: correlation with duration of illness

Moberg, P. J., Doty, R. L., Turetsky, B. I., Arnold, S. E., Mahr, R. N., Gur, R. C., Bilker, W. B., & Gur, R. E. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.7.1016 · Cited by 118 · see citing works

Adjunctive intranasal oxytocin improves verbal memory in people with schizophrenia

Feifel, D., MacDonald, K. S., Cobb, P., & Minassian, A. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.05.018 · Cited by 117 · see citing works

Neuropsychological profiles in individuals at clinical high risk for psychosis: Relationship to psychosis and intelligence

Woodberry, K. A., Seidman, L. J., Giuliano, A. J., Verdi, M., Cook, W. L., & McFarlane, W. R. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.06.021 · Cited by 116 · see citing works

The human brain representation of odor identification

Kjelvik, G., Evensmoen, H. R., Brezova, V., & Haberg, A. K. (2012) · Journal of Neurophysiology · doi:10.1152/jn.01036.2010 · Cited by 114 · see citing works

Vasopressin, oxytocin, and social odor recognition

Wacker, D. W., & Ludwig, M. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.08.014 · Cited by 112 · see citing works

Olfactory Functioning in Schizophrenia: Relationship to Clinical, Neuropsychological, and Volumetric MRI Measures

Moberg, P. J., Arnold, S. E., Doty, R. L., Gur, R. E., Balderston, C. C., Roalf, D. R., Gur, R. C., Kohler, C. G., Kanes, S., Siegel, S. J., et al. (2006) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390500434409 · Cited by 106 · see citing works

Olfactory deficits, cognition and negative symptoms in early onset psychosis

Corcoran, C. M., Whitaker, A. H., Coleman, E. A., Fried, J., Feldman, J., Goudsmit, N., & Malaspina, D. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.07.028 · Cited by 99 · see citing works

Sex differences in olfactory function in schizophrenia

Kopala, L. C., Clark, C., & Hurwitz, T. A. (1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.10.1320 · Cited by 98 · see citing works

Olfaction and Social Drive in Schizophrenia

Malaspina, D., & Coleman, E. A. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.6.578 · Cited by 95 · see citing works

Olfactory memory in unmedicated schizophrenics

Wu, J. C., Buchsbaum, M. S., Moy, K., Denlea, N., Kesslak, P. J., Tseng, H., Plosnaj, D., Hetu, M., Potkin, S. G., Bracha, H. S., et al. (1993) · Schizophrenia Research · doi:10.1016/0920-9964(93)90008-7 · Cited by 90 · see citing works

Impaired Olfactory Identification in Relatives of Patients With Familial Schizophrenia

Kopala, L. C., Good, K. P., Morrison, K., Bassett, A. S., Alda, M., & Honer, W. G. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1286 · Cited by 87 · see citing works

Left temporo-limbic and orbital dysfunction in schizophrenia during odor familiarity and hedonicity judgments

Plailly, J., d’Amato, T., Saoud, M., & Royet, J. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.06.056 · Cited by 75 · see citing works

Odor identification, eye tracking and deficit syndrome schizophrenia

Malaspina, D., Coleman, E. A., Goetz, R. R., Harkavy‐Friedman, J., Corcoran, C. M., AMADOR, X. F., Yale, S. A., & Gorman, J. M. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01319-1 · Cited by 71 · see citing works

An Odor-Specific Threshold Deficit Implicates Abnormal Intracellular Cyclic AMP Signaling in Schizophrenia

Turetsky, B. I., & Moberg, P. J. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07071210 · Cited by 71 · see citing works

Neuropsychological, neurological and symptom correlates of impaired olfactory identification in schizophrenia

STEDMAN, T. J., & Clair, A. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00021-8 · Cited by 68 · see citing works

Olfactory Dysfunction in Schizophrenia: A Review of Neuroanatomy and Psychophysiological Measurements

Nguyen, A. D., Shenton, M. E., & Levitt, J. J. (2010) · Harvard Review of Psychiatry · doi:10.3109/10673229.2010.511060 · Cited by 65 · see citing works

Various Bilateral Olfactory Deficits in Male Patients With Schizophrenia

Rupp, C. I. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi018 · Cited by 65 · see citing works

Negative symptoms of schizophrenia correlate with impairment on the University of Pennsylvania Smell Identification Test

Ishizuka, K., Tajinda, K., Colantuoni, C., Morita, M., Winicki, J. M., Le, C., Lin, S. Y., Schretlen, D. J., Sawa, A., & Cascella, N. G. (2009) · Neuroscience Research · doi:10.1016/j.neures.2009.10.001 · Cited by 62 · see citing works

Olfactory Identification Deficits in First-Episode Psychosis May Predict Patients at Risk for Persistent Negative and Disorganized or Cognitive Symptoms

Good, K. P., Whitehorn, D., Rui, Q., Milliken, H., & Kopala, L. C. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.5.932 · Cited by 59 · see citing works

Olfactory identification ability in pre- and postmenopausal women with schizophrenia

Kopala, L. C., Good, K. P., & Honer, W. G. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00224-q · Cited by 59 · see citing works

Olfactory processing in schizophrenia, non-ill first-degree family members, and young people at-risk for psychosis

Kamath, V. J., Turetsky, B. I., Calkins, M. E., Kohler, C. G., Conroy, C. G., Borgmann‐Winter, K. E., Gatto, D. E., Gur, R. E., & Moberg, P. J. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.615862 · Cited by 57 · see citing works

Olfactory Hedonic Judgment in Patients With Deficit Syndrome Schizophrenia

Strauss, G. P., Allen, D. N., Ross, S., Duke, L. A., & Schwartz, J. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn178 · Cited by 57 · see citing works

Odor Hedonic Capacity and Anhedonia in Schizophrenia and Unaffected First-Degree Relatives of Schizophrenia Patients

Kamath, V. J., Moberg, P. J., Kohler, C. G., Gur, R. C., & Turetsky, B. I. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr050 · Cited by 55 · see citing works

Olfactory Function in Monozygotic Twins Discordant for Schizophrenia

Kopala, L. C., Good, K. P., Torrey, Ε. F., & Honer, W. G. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.1.134 · Cited by 53 · see citing works

Scent of a disorder: Olfactory functioning in schizophrenia

Moberg, P. J., & Turetsky, B. I. (2003) · Current Psychiatry Reports · doi:10.1007/s11920-003-0061-x · Cited by 49 · see citing works

Olfactory impairment in monozygotic twins discordant for schizophrenia

Ugur, T., Weisbrod, M., Franzek, E., Pf�ller, U., & Sauer, H. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0536-8 · Cited by 45 · see citing works

Unirhinal Olfactory Function in Schizophrenia Patients and First-Degree Relatives

Roalf, D. R., Turetsky, B. I., Owzar, K., Balderston, C. C., Johnson, S. C., Brensinger, C. M., Gur, R. E., Siegel, S. J., & Moberg, P. J. (2006) · Journal of Neuropsychiatry · doi:10.1176/jnp.2006.18.3.389 · Cited by 42 · see citing works

Neurodevelopmental involvement in schizophrenia: the olfactory epithelium as an alternative model for research

Cascella, N. G., Takaki, M., Lin, S. Y., & Sawa, A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04628.x · Cited by 37 · see citing works

Identification of pleasant, neutral, and unpleasant odors in schizophrenia

Kamath, V. J., Turetsky, B. I., & Moberg, P. J. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2010.12.011 · Cited by 32 · see citing works

Odor Identification Impairments in Schizophrenia: Relationship With Demographic Measures, Clinical Variables, and Diagnostic Subtypes

Coleman, E. A., Goetz, R. R., Leitman, D., Yale, S. A., Stanford, A. D., Gorman, J. M., & Malaspina, D. (2002) · CNS Spectrums · doi:10.1017/s1092852900022252 · Cited by 30 · see citing works

Psychotropic properties of oxytocin

Vd, B., Sm, T., & Lozhkina, T. K. (1986) · Neuroscience and Behavioral Physiology · doi:10.1007/bf01186517 · Cited by 27 · see citing works

Negative symptoms in patients with schizophrenia with special reference to the primary versus secondary distinction.

Fleischhacker, W. W. (2000) · PubMed · Cited by 26 · see citing works

OLFACTION IN SCHIZOPHRENIA

Dunn, T. P., & Weller, M. P. I. (1989) · Perceptual and Motor Skills · doi:10.2466/pms.1989.69.3.833 · Cited by 23 · see citing works

Olfactory identification in young relatives at risk for schizophrenia

Keshavan, M. S., Vora, A., Montrose, D. M., Diwadkar, V. A., & Sweeney, J. A. (2009) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2009.00390.x · Cited by 17 · see citing works

Is the odour identification deficit in schizophrenia influenced by odour hedonics?

Kamath, V. J., Bedwell, J. S., & Compton, M. T. (2011) · Cognitive Neuropsychiatry · doi:10.1080/13546805.2011.552561 · Cited by 12 · see citing works

[Psychotropic properties of oxytocin].

Vd, B., Sm, T., & Tk, L. (1984) · PubMed · Cited by 11 · see citing works

Oxytocin pathway gene networks in the human brain

Quintana, D. S., Rokicki, J., van der Meer, D., Alnæs, D., Kaufmann, T., Córdova-Palomera, A., Dieset, I., Andreassen, O. A., & Westlye, L. T. (2019) · Nature Communications · doi:10.1038/s41467-019-08503-8 · Cited by 354 · see citing works

Negative symptoms of schizophrenia: Clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment

Millan, M. J., Fone, K. C. F., Steckler, T., & Horan, W. P. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.03.008 · Cited by 354 · see citing works

Oxytocin-Augmented Social Cognitive Skills Training in Schizophrenia

Davis, M. C., Green, M. F., Lee, J., Horan, W. P., Senturk, D., Clarke, A. D., & Marder, S. R. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.68 · Cited by 149 · see citing works

Oxytocin administration enhances controlled social cognition in patients with schizophrenia

Woolley, J. D., Chuang, B., Lam, O., Lai, W., O’Donovan, A., Rankin, K. P., Mathalon, D. H., & Vinogradov, S. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.04.024 · Cited by 116 · see citing works

Agile delivery of protein therapeutics to CNS

Yi, X., Manickam, D. S., Brynskikh, A. M., & Kabanov, A. V. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.017 · Cited by 115 · see citing works

The promise and pitfalls of intranasally administering psychopharmacological agents for the treatment of psychiatric disorders

Quintana, D. S., Guastella, A. J., Westlye, L. T., & Andreassen, O. A. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.166 · Cited by 107 · see citing works

A Review of Oxytocin’s Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia

Feifel, D., Shilling, P. D., & MacDonald, K. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.07.025 · Cited by 110 · see citing works

Pharmacological approaches to treating negative symptoms: A review of clinical trials

Arango, C., Garibaldi, G. M., & Marder, S. R. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.07.026 · Cited by 101 · see citing works

Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward

Bradley, E., & Woolley, J. D. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.05.007 · Cited by 88 · see citing works

Potential of Oxytocin in the Treatment of Schizophrenia

Shilling, P. D., & Feifel, D. (2016) · CNS Drugs · doi:10.1007/s40263-016-0315-x · Cited by 82 · see citing works

Sex hormones and oxytocin augmentation strategies in schizophrenia: A quantitative review

Heringa, S. M., Begemann, M., Goverde, A. J., & Sommer, I. E. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.04.002 · Cited by 82 · see citing works

Intranasal Oxytocin May Improve High-Level Social Cognition in Schizophrenia, But Not Social Cognition or Neurocognition in General: A Multilevel Bayesian Meta-analysis

Bürkner, P., Williams, D. R., Simmons, T. C., & Woolley, J. D. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx053 · Cited by 80 · see citing works

Oxytocin in Schizophrenia: Pathophysiology and Implications for Future Treatment

Goh, K. K., Chen, C.-H., & Lane, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042146 · Cited by 78 · see citing works

The past and future of novel, non-dopamine-2 receptor therapeutics for schizophrenia: A critical and comprehensive review

Girgis, R. R., Zoghbi, A. W., Javitt, D. C., & Lieberman, J. A. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.07.006 · Cited by 73 · see citing works

Exogenous effects of oxytocin in five psychiatric disorders: a systematic review, meta-analyses and a personalized approach through the lens of the social salience hypothesis

Peled‐Avron, L., Abu-Akel, A. M., & Shamay‐Tsoory, S. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.04.023 · Cited by 73 · see citing works

Effects of Oxytocin on Neural Response to Facial Expressions in Patients with Schizophrenia

Shin, N. Y., Park, H. Y., Jung, W. H., Park, J. W., Yun, J., Jang, J. H., Kim, S. N., Han, H. J., Kim, S.-Y., Kang, D., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.41 · Cited by 69 · see citing works

Oxytocin: Parallel Processing in the Social Brain?

Dölen, G. (2015) · Journal of Neuroendocrinology · doi:10.1111/jne.12284 · Cited by 65 · see citing works

Chronic oxytocin administration as a tool for investigation and treatment: A cross-disciplinary systematic review

Horta, M., Kaylor, K., Feifel, D., & Ebner, N. C. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.10.012 · Cited by 62 · see citing works

Psychopharmacology of the negative symptoms: Current status and prospects for progress

Davis, M. C., Horan, W. P., & Marder, S. R. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.10.010 · Cited by 59 · see citing works

Intranasal oxytocin enhances neural processing of monetary reward and loss in post-traumatic stress disorder and traumatized controls

Nawijn, L., van Zuiden, M., Koch, S. B. J., Frijling, J. L., Veltman, D. J., & Olff, M. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.01.020 · Cited by 59 · see citing works

Effects of intranasal oxytocin on symptoms of schizophrenia: A multivariate Bayesian meta-analysis

Williams, D. R., & Bürkner, P. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.10.013 · Cited by 58 · see citing works

Intranasal delivery of antipsychotic drugs

Katare, Y. K., Piazza, J. E., Bhandari, J., Daya, R. P., Akilan, K., Simpson, M. J., Hoare, T. R., & Mishra, R. K. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.11.027 · Cited by 57 · see citing works

Plasma oxytocin levels predict olfactory identification and negative symptoms in individuals with schizophrenia

Strauss, G. P., Keller, W. R., Koenig, J. I., Gold, J. M., Ossenfort, K. L., & Buchanan, R. W. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2014.12.023 · Cited by 54 · see citing works

Effects of oxytocin and genetic variants on brain and behaviour: Implications for treatment in schizophrenia

Bartholomeusz, C. F., Ganella, E. P., Labuschagne, I., Bousman, C., & Pantelis, C. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.06.007 · Cited by 54 · see citing works

Oxytocin and social cognition in affective and psychotic disorders

Pérez-Rodríguez, M. M., Mahon, K., Russo, M., Ungar, A. K., & Burdick, K. E. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.07.012 · Cited by 52 · see citing works

Efficacy and safety of oxytocin augmentation therapy for schizophrenia: an updated systematic review and meta-analysis of randomized, placebo-controlled trials

Oya, K., Matsuda, Y., Matsunaga, S., Kishi, T., & Iwata, N. (2015) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-015-0634-9 · Cited by 51 · see citing works

Plasma oxytocin levels predict social cue recognition in individuals with schizophrenia

Strauss, G. P., Keller, W. R., Koenig, J. I., Gold, J. M., Frost, K. H., & Buchanan, R. W. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.01.034 · Cited by 51 · see citing works

Adjunctive intranasal oxytocin for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials

Zheng, W., Zhu, X.-M., Zhang, Q.-E., Yang, X.-H., Cai, D.-B., Li, L., Li, X.-B., Ng, C. H., Ungvari, G. S., Ning, Y.-P., et al. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.12.007 · Cited by 45 · see citing works

Association between Genetic Variation in the Oxytocin Receptor Gene and Emotional Withdrawal, but not between Oxytocin Pathway Genes and Diagnosis in Psychotic Disorders

Haram, M., Tesli, M., Bettella, F., Djurovic, S., Andreassen, O. A., & Melle, I. S. (2015) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2015.00009 · Cited by 42 · see citing works

Heterogeneity in response to repeated intranasal oxytocin in schizophrenia and autism spectrum disorders: A meta‐analysis of variance

Martins, D., Paduraru, M., & Paloyelis, Y. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15451 · Cited by 43 · see citing works

Do we need oxytocin to treat schizophrenia? A randomized clinical trial

Dagani, J., Sisti, D., Abelli, M., Paolo, L. D., Pini, S., Raimondi, S., Rocchi, M., Saviotti, F. M., Scocco, P., Totaro, S., et al. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.02.011 · Cited by 41 · see citing works

A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With Schizophrenia

Buchanan, R. W., Kelly, D. L., Weiner, E., Gold, J. M., Strauss, G. P., Koola, M. M., McMahon, R. P., & Carpenter, W. T. (2017) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000720 · Cited by 40 · see citing works

Intranasal Oxytocin for Negative Symptoms of Schizophrenia: Systematic Review, Meta-Analysis, and Dose-Response Meta-Analysis of Randomized Controlled Trials

Sabé, M., Zhao, N., Crippa, A., Strauss, G. P., & Kaiser, S. (2021) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyab020 · Cited by 40 · see citing works

Oxytocin system dysfunction as a common mechanism underlying metabolic syndrome and psychiatric symptoms in schizophrenia and bipolar disorders

Quintana, D. S., Dieset, I., Elvsåshagen, T., Westlye, L. T., & Andreassen, O. A. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2016.12.004 · Cited by 39 · see citing works

Oxytocin and Behavior: Evidence for Effects in the Brain

Stevens, F. L., Wiesman, O., Feldman, R., Hurley, R. A., & Taber, K. H. (2013) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.13030061 · Cited by 35 · see citing works

Drug repurposing and emerging adjunctive treatments for schizophrenia

Bumb, J. M., Enning, F., & Leweke, F. M. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1032248 · Cited by 34 · see citing works

Decreased Serum Oxytocin and Increased Homocysteine in First-Episode Schizophrenia Patients

Liu, Y., Tao, H., Yang, X., Huang, K., Zhang, X., & Li, C. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00217 · Cited by 32 · see citing works

Normal repetitive and abnormal stereotyped behavior of nonretarded infants and young mentally retarded children.

Schwartz, S. S., Gallagher, R. J., & Berkson, G. (1986) · PubMed · Cited by 32 · see citing works

Oxytocin to modulate emotional processing in schizophrenia: A randomized, double-blind, cross-over clinical trial

Brambilla, M., Cotelli, M., Manenti, R., Dagani, J., Sisti, D., Rocchi, M., Balestrieri, M., Pini, S., Raimondi, S., Saviotti, F. M., et al. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.08.001 · Cited by 31 · see citing works

Efficacy of intranasal administration of artesunate in experimental cerebral malaria

Marijon, A., Bonnot, G., Fourier, A., Bringer, C., Lavoignat, A., Gagnieu, M., Bienvenu, A., & Picot, S. (2014) · Malaria Journal · doi:10.1186/1475-2875-13-501 · Cited by 30 · see citing works

The effects of adjunctive intranasal oxytocin in patients with schizophrenia

Ota, M., Yoshida, S., Nakata, M., Yada, T., & Kunugi, H. (2017) · Postgraduate Medicine · doi:10.1080/00325481.2018.1398592 · Cited by 27 · see citing works

Oxytocin improves probabilistic reversal learning but not effortful motivation in Brown Norway rats

Roberts, B. Z., Young, J. W., He, Y. V., Cope, Z. A., Shilling, P. D., & Feifel, D. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.02.028 · Cited by 24 · see citing works

Relationship of plasma oxytocin levels to baseline symptoms and symptom changes during three weeks of daily oxytocin administration in people with schizophrenia

Lee, M. R., Wehring, H. J., McMahon, R. P., Liu, F., Linthicum, J., Verbalis, J. G., Buchanan, R. W., Strauss, G. P., Rubin, L. H., & Kelly, D. L. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.02.014 · Cited by 24 · see citing works

Epistatic and independent effects on schizophrenia-related phenotypes following co-disruption of the risk factors neuregulin-1 × DISC1

O’Tuathaigh, C. M. P., Fumagalli, F., Desbonnet, L., Perez-Branguli, F., Moloney, G., Loftus, S., O’Leary, C., Petit, E., Cox, R., Tighe, O., et al. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw120 · Cited by 22 · see citing works

Intranasal oxytocin increases heart-rate variability in men at clinical high risk for psychosis: a proof-of-concept study

Martins, D., Davies, C., Micheli, A. D., Oliver, D., Krawczun-Rygmaczewska, A., Fusar‐Poli, P., & Paloyelis, Y. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00890-7 · Cited by 24 · see citing works

Potential link between genetic polymorphisms of catechol-O-methyltransferase and dopamine receptors and treatment efficacy of risperidone on schizophrenia

Han, J., Li, Y., & Wang, X. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s148824 · Cited by 20 · see citing works

The effects of intranasal oxytocin on the efficacy of psychotherapy for major depressive disorder: a pilot randomized controlled trial

Ellenbogen, M. A., Cardoso, C., Serravalle, L., Vadaga, K. K., & Joober, R. (2024) · Psychological Medicine · doi:10.1017/s0033291724000217 · Cited by 20 · see citing works

Oxytocin and Schizophrenia Spectrum Disorders

Ettinger, U., Hurlemann, R., & Chan, R. C. K. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2017_27 · Cited by 16 · see citing works

Oxytocin administration selectively improves olfactory detection thresholds for lyral in patients with schizophrenia

Woolley, J. D., Lam, O., Chuang, B., Ford, J. M., Mathalon, D. H., & Vinogradov, S. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.12.018 · Cited by 14 · see citing works

The Effect of Intranasal Oxytocin on Measures of Social Cognition in Schizophrenia: A Negative Report

Lee, M. R., Wehring, H. J., McMahon, R., Liu, F., Linthicum, J., Buchanan, R., Strauss, G., Rubin, L., & Kelly, D. (2019) · Journal of Psychiatry and Brain Science · doi:10.20900/jpbs.20190001 · Cited by 13 · see citing works

Schizophrenia and alcohol dependence: Diverse clinical effects of oxytocin and their evolutionary origins

Pedersen, C. A. (2014) · Brain Research · doi:10.1016/j.brainres.2014.01.050 · Cited by 12 · see citing works

Oxytocin gene networks in the human brain: A gene expression and large-scale fMRI meta-analysis studyPreprint

Quintana, D. S. (2018) · OSF Preprints (OSF Preprints) · Cited by 12 · see citing works

Oxytocin gene networks in the human brain: A gene expression and large-scale fMRI meta-analysis studyPreprint

Quintana, D. S., Rokicki, J., van der Meer, D., Alnæs, D., Kaufmann, T., Córdova‐Palomera, A., Dieset, I., Andreassen, O. A., & Westlye, L. T. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/149526 · Cited by 12 · see citing works

Oxytocin, the panacea for long-COVID? a review

Diep, P.-T., Chaudry, M., Dixon, A., Chaudry, F., & Kasabri, V. N. (2022) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2021-0034 · Cited by 10 · see citing works

The effects of oxytocin and galantamine on objectively-defined vocal and facial expression: Data from the CIDAR study

Cohen, A. S., Mitchell, K. R., Strauss, G. P., Blanchard, J. J., Buchanan, R. W., Kelly, D. L., Gold, J. M., McMahon, R. P., Adams, H. A., & Carpenter, W. T. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.01.028 · Cited by 10 · see citing works

Up-regulated expression of oxytocin mRNA in peripheral blood lymphocytes from first-episode schizophrenia patients

Yang, X., Tang, Y., Wei, Q., Lang, B., Tao, H., Zhang, X., Liu, Y., & Tang, A. (2017) · Oncotarget · doi:10.18632/oncotarget.20252 · Cited by 9 · see citing works

The Use of Oxytocin in Personality Disorders: Rationale and Current Status

Pérez-Rodríguez, M. M., Derish, N. E., & New, A. S. (2014) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-014-0026-1 · Cited by 7 · see citing works

Oxytocin-pathway polygenic scores for severe mental disorders and metabolic phenotypes in the UK Biobank

Winterton, A., Bettella, F., de Lange, A. G., Haram, M., Steen, N. E., Westlye, L. T., Andreassen, O. A., & Quintana, D. S. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01725-9 · Cited by 6 · see citing works

Utility of Downstream Biomarkers to Assess and Optimize Intranasal Delivery of Oxytocin

DuBois, M. C., Tseng, A., Francis, S. M., Haynos, A. F., Peterson, C. B., & Jacob, S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061178 · Cited by 5 · see citing works

Oxytocin administration versus emotion training in healthy males: considerations for future research

Daughters, K., Rees, A., Hunnikin, L. M., Wells, A. E., Hall, J., & van Goozen, S. H. M. (2022) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2021.0056 · Cited by 3 · see citing works

Acute Management of Schizophrenia

Janicak, P. G. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0656-7_7 · Cited by 3 · see citing works

Oxytocin pathway polygenic risk scores for severe mental disorder and metabolic phenotypes in the UK BiobankPreprint

Winterton, A., Bettella, F., de Lange, A. G., Haram, M., Steen, N. E., Westlye, L. T., Andreassen, O. A., & Quintana, D. S. (2021) · doi:10.31219/osf.io/sw3fg · Cited by 3 · see citing works

Intranasal Oxytocin Combined With Social Skills Training for Schizophrenia: An Add-on Randomized Controlled Trial

Saporta, L., Feldman, R., Levi, L. W., Davidson, M., Burshtein, S., Gur, R. C., Zagoory‐Sharon, O., Amiaz, R., Park, J., Davis, J. M., et al. (2024) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgae022 · Cited by 2 · see citing works

Coding Errors Lead to Unsupported Conclusions

Williams, D. E., & Bürkner, P. (2020) · Meta-Psychology · doi:10.15626/mp.2018.872 · Cited by 2 · see citing works

Data extraction and statistical errors: A quantitative critique of Gumley, Braehler, and Macbeth (2014)

Williams, D. R., & Bürkner, P. (2017) · British Journal of Clinical Psychology · doi:10.1111/bjc.12130 · Cited by 2 · see citing works

Coding errors lead to unsupported conclusions: a critique of Hofmann et al. (2015)Preprint

Williams, D. R., & Bürkner, P. (2017) · doi:10.31234/osf.io/2jpdb · Cited by 2 · see citing works

Symptômes négatifs de la schizophrénie : nouvelles approches pharmacologiques

Lodovighi, M.-A., Palomba, A., Belzeaux-R, R., Adida, M., & Azorin, J. (2015) · L Encéphale · doi:10.1016/s0013-7006(16)30010-0 · Cited by 1 · see citing works

Chloride transporters in physiological brain development and neurodevelopmental disorders: The case of the Down syndrome

Savardi, A., Ziogas, I., Bolla, M., & Cancedda, L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815318-5.00021-2 · Cited by 1 · see citing works

Role of oxytocin in social cognition in psychosis spectrum disorders

Benavides, C., Fred-Torres, S., Rutter, S., Larsen, E. M., Fastman, J., Bulbena‐Cabré, A., Lepow, L., Mahon, K., Russo, M., Ungar, A. K., et al. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815315-4.00006-9 · Cited by 1 · see citing works

Oxytocin Effects on Chemosensory Function in a Clinical Setting—a Preliminary Study

Burke, S., Graf, R., Ochsenbein‐Kölble, N., & Hummel, T. R. (2015) · Chemosensory Perception · doi:10.1007/s12078-015-9185-8 · Cited by 1 · see citing works

Novel Approaches for Managing Schizophrenia

Rado, J. T., Hernandez, E. I., & Janicak, P. G. (2013) · Psychopharm Review · doi:10.1097/01.psyphr.0000437783.35936.18

EFFET DE LA STIMULATION MAGNETIQUE TRANSCRANIENNE REPETEE SUR LES SYMPTOMES NEGATIFS ET LE DEFICIT EN THEORIE DE L'ESPRIT DANS LA SCHIZOPHRENIE

Paquin, N. (2015) · HAL

Oxytocin, Schizophrenia, Social Recognition, and Odor Identification: Nothing to Sneeze At

Silver, J. (2013) · Journal watch · doi:10.1056/jp201303180000003

The genetic network underlying anxiety disorder and its small molecular level supports

Liao, J., Cheadle, C., Cao, H., & Rao, V. (2016) · Journal of Psychiatry and Brain Science · doi:10.20900/jpbs.20160013

Novel Approaches for Managing Schizophrenia

Janicak, P. G. (2013) · Psychopharm Review · doi:10.1097/01.psyphr.0000433989.65396.2b

Aromatherapy: A Novel Approach to Schizophrenia Treatment

Меркулова, Е. В. (2024) · Royal Society of Chemistry eBooks · doi:10.1039/9781837672059-00133

Does intranasal oxytocin reduce symptoms of mental disorders? A meta-analysis of clinical trials

Bonnieux, J. N., Gumuchian, S. T., Harboun, A., Trespalacios, F., Bélisle, K.-A., Haddad, A., Quintus-Bosz, O., McLellan, A., Chester-Trudel, L., Garred, D., et al. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106749

Translational pathways of oxytocin therapy in schizophrenia: bridging negative symptom domains and neural mechanisms

Ji, L., (19312), X. W., Li, Y., Zhao, W., Du, X., Gao, Y., Li, J., & Liu, S. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04145-9

Oxytocin administration selectively improves olfactory detection thresholds for lyral in patients with schizophrenia

Woolley, J. D., Lam, O., Chuang, B., Ford, J. M., Mathalon, D. H., & Vinogradov, S. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.12.018 · Cited by 14 · see citing works

Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia

Pedersen, C. A., Gibson, C. M., Rau, S. W., Salimi, K., Smedley, K. L., Casey, R. L., Leserman, J., Jarskog, L. F., & Penn, D. L. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.07.027 · Cited by 305 · see citing works

Intranasal Oxytocin as an Adjunct to Risperidone in Patients with Schizophrenia

Modabbernia, A., Rezaei, F., Salehi, B., Jafarinia, M., Ashrafi, M., Tabrizi, M. H., Hosseini, S. M. R., Tajdini, M., Ghaleiha, A., & Akhondzadeh, S. (2012) · CNS Drugs · doi:10.1007/s40263-012-0022-1 · Cited by 107 · see citing works

Plasma oxytocin levels predict olfactory identification and negative symptoms in individuals with schizophrenia

Strauss, G. P., Keller, W. R., Koenig, J. I., Gold, J. M., Ossenfort, K. L., & Buchanan, R. W. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2014.12.023 · Cited by 54 · see citing works

The effects of adjunctive intranasal oxytocin in patients with schizophrenia

Ota, M., Yoshida, S., Nakata, M., Yada, T., & Kunugi, H. (2017) · Postgraduate Medicine · doi:10.1080/00325481.2018.1398592 · Cited by 27 · see citing works